CEO Joaquin Duato highlighted "very strong third quarter results" and described Johnson & Johnson as being in a "powerful new era of growth." The company reported operational sales growth of 5.4% and ...
Johnson & Johnson posts strong Q3 2025 with robust sales, new acquisitions, and FDA approvals expanding oncology and CNS ...
The case involves a California woman who died from mesothelioma, a rare cancer. Her family claimed Johnson and Johnson’s talc powder products were to blame. By Kailyn Rhone A Los Angeles jury ordered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback